Hematopoietic cell l-selectin ligand (hll) and therapeutics...

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 14/705 (2006.01) A61K 35/12 (2006.01) A61K 35/14 (2006.01) A61K 35/28 (2006.01) A61K 39/395 (2006.01) A61K 47/48 (2006.01) C07K 16/28 (2006.01) C12Q 1/24 (2006.01) G01N 33/554 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2202472

An isolated and purified glycoprotein and functional analogs are disclosed. The glycoproteins are characterized by being expressed on at least primitive hematopoietic cells, and being a ligand for L-selectin. The binding of ligand to L-selectin is not inhibitied by anti-CD34 antibodies nor by MECA 79 monoclonal antibody.

L'invention concerne une glycoprotéine isolée et purifiée et des analogues fonctionnels. Les glycoprotéines sont caractérisées en ce qu'elles sont exprimées sur au moins des cellules hématopoïétiques primitives, et qu'elles constituent un ligand pour L-sélectine. La liaison du ligand sur L-sélectine n'est pas empêchée par des anticorps anti-CD34 ni par l'anticorps monoclonal MECA 79.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Hematopoietic cell l-selectin ligand (hll) and therapeutics... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hematopoietic cell l-selectin ligand (hll) and therapeutics..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hematopoietic cell l-selectin ligand (hll) and therapeutics... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2031331

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.